Juno And Other Gene Therapy Players Are Hot Despite Ongoing Pricing Debates – Forbes
Forbes |
Juno And Other Gene Therapy Players Are Hot Despite Ongoing Pricing Debates
Forbes More than 300 pharma and biotech companies are working on gene therapy products, and Juno ties for first place on that list when ranked by the size of its development pipeline, according to a recent report from Informa Pharma. Both Juno and Regenexbio … |
